Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 16,988 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Mr. Deepak Nath est le Chief Executive Officer de Smith & Nephew plc, il a rejoint l'entreprise depuis 2022.
Quelle est la performance du prix de l'action Smith & Nephew SNATS, Inc. ?
Le prix actuel de Smith & Nephew SNATS, Inc. est de $32.18, il a augmenté de 0.76% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Smith & Nephew plc ?
Smith & Nephew plc appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Smith & Nephew plc ?
La capitalisation boursière actuelle de Smith & Nephew plc est de $13.6B
Est-ce que Smith & Nephew plc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 19 analystes ont établi des notations d'analystes pour Smith & Nephew plc, y compris 6 achat fort, 8 achat, 9 maintien, 0 vente et 6 vente forte